Even limited hearing loss might be associated with cognitive decline. If true, early intervention with hearing aids might help people have better cognitive performance.
Michael Johns III, MD, online editor for JAMA Otolaryngology, speaks with Justin Golub, MD, MS, assistant professor of otolaryngology at Columbia University, whose research has shown that very mild hearing loss can be associated with cognitive disability.
With questionable coronavirus content flooding airwaves and online channels, what’s being done to limit its impact?
In this episode:
00:57 The epidemiology of misinformation
As the pandemic spreads, so does a tidal wave of misinformation and conspiracy theories. We discuss how researchers’ are tracking the spread of questionable content, and ways to limit its impact.
Our hosts pick out things that have made them smile in the last week, including walks in new places, an update on the Isolation Choir, and a very long music playlist.
Scientists around the world are concerned about the impacts that the pandemic will have on their funding and research projects. We hear from two who face uncertainty, and get an update on the plans put in place by funding organisations to support their researchers.
An estimated 80 million people live with a neurodegenerative disease, with this number expected to double by 2050. Despite decades of research and billions in funding, there are no medications that can slow, much less stop, the progress of these diseases. The time to rethink degenerative brain disorders has come. With no biological boundaries between neurodegenerative diseases, illnesses such as Parkinson’s and Alzheimer’s result from a large spectrum of biological abnormalities, hampering effective treatment.
Acclaimed neurologist Dr Alberto Espay and Parkinson’s advocate Benjamin Stecher present compelling evidence that these diseases should be targeted according to genetic and molecular signatures rather than clinical diagnoses. There is no Parkinson’s or Alzheimer’s, simply people with Parkinson’s or Alzheimer’s. An incredibly important story never before told, Brain Fables is a wakeup call to the scientific community and society, explaining why we have no effective disease-modifying treatments, and how we can get back on track.
Understanding how the body clears the new coronavirus is becoming more important as the U.S. begins to reopen. WSJ’s Daniela Hernandez explains how the body fights infection and why feeling better doesn’t equal being virus-free.
Monocle 24 checks in on Switzerland’s plans to further ease coronavirus restrictions and ask whether the country is setting an example that others should follow.
Plus: the weekend’s newspapers and top stories. From Milan: Salone highlights, interviews and a daily running guide.